SEC Form 4 · accession 0001144204-16-096682
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Randall Brenneman
Officer — Chief Financial Officer
Period of report
Apr 25, 2016
Accepted (ET)
Apr 27, 2016 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.23 | Apr 25, 2016 | A | 41,732 | A | — | Apr 25, 2026 | Common Stock | 41,732 | 41,732 | D |
Explanation of responses
- F1The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 25, 2017, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the Reporting Person's continued employment through each such vesting date.